Showing results (261-270 of 375) with videos related to

Sort By:
Pageof 38
Plos One|January 18, 2017
Intensive versus Guideline Blood Pressure and Lipid Lowering in Patients with Previous Stroke: Main Results from the Pilot 'Prevention of Decline in Cognition after Stroke Trial' (PODCAST) Randomised Controlled TrialPhilip M Bath, Polly Scutt, Daniel J Blackburn, et al.
Neurology|September 13, 2024
Duration of Benefit and Risk of Dual Antiplatelet Therapy up to 72 Hours After Mild Ischemic Stroke and Transient Ischemic AttackLing Guan, Shangrong Han, S Claiborne Johnston, et al.
Annals of Internal Medicine|October 31, 2022
Ticagrelor-Aspirin Versus Clopidogrel-Aspirin Among <i>CYP2C19</i> Loss-of-Function Carriers With Minor Stroke or Transient Ischemic Attack in Relation to Renal Function: A Post Hoc Analysis of the CHANCE-2 TrialAnxin Wang, Xuewei Xie, Xue Tian, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|December 15, 2015
A cross-laboratory preclinical study on the effectiveness of interleukin-1 receptor antagonist in strokeSamaneh Maysami, Raymond Wong, Jesus M Pradillo, et al.
European Stroke Journal|August 20, 2021
Regulatory delays in a multinational clinical stroke trialJeroen C de Jonge, Hendrik Reinink, Bridget Colam, et al.
Journal of Atherosclerosis and Thrombosis|July 24, 2025
Effect of Stroke Severity on Efficacy and Safety of Indobufen versus Aspirin in Patients with Moderate to Severe Stroke: Results from the INSURE Randomized Clinical TrialMengxing Wang, Shanyu Pu, Aoming Jin, et al.
Clinical Trials (London, England)|July 16, 2020
Methodologies for pragmatic and efficient assessment of benefits and harms: Application to the SOCRATES trialScott R Evans, Mikael Knutsson, Pierre Amarenco, et al.
Cell Reports. Medicine|February 6, 2026
The effect of dual antiplatelet therapy in different patterns of watershed infarction: Subgroup analysis of the INSPIRES trialChenhui Liu, Ying Li, Zhangxinyi Liu, et al.
Neurology|January 5, 2024
One-Year Outcomes of Early Therapy With Ticagrelor vs Clopidogrel in <i>CYP2C19</i> Loss-of-Function Carriers With Stroke or TIA TrialXia Meng, Anxin Wang, Xue Tian, et al.
Stroke|December 20, 2024
Dual Antiplatelet Treatment up to 72 Hours After Ischemic Stroke Stratified by Risk Profile: A Post Hoc AnalysisYanli Zhang, Xuan Wang, Ying Gao, et al.
Pageof 38